Literature DB >> 19123044

Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin.

Catarina Santos1, Ana Peixoto, Patrícia Rocha, Ana Vega, Maria José Soares, Nuno Cerveira, Susana Bizarro, Manuela Pinheiro, Deolinda Pereira, Helena Rodrigues, Fernando Castro, Rui Henrique, Manuel R Teixeira.   

Abstract

We investigated the functional effect of the missense variant c.211A>G (R71G) localized at position -2 of exon 5 donor splice site in the BRCA1 gene and evaluated whether Portuguese and Galician families with this mutation share a common ancestry. Three unrelated Portuguese breast/ovarian cancer families carrying this variant were studied through qualitative and quantitative transcript analyses. We also evaluated the presence of loss of heterozigosity and the histopathologic characteristics of the carcinomas in those families. Informative families (two from Portugal and one from Galicia) were genotyped for polymorphic microsatellite markers flanking BRCA1 to reconstruct haplotypes. Qualitative RNA analysis revealed the presence of two alternative transcripts both in carriers of the BRCA1 R71G variant and in controls. Semi-quantitative fragment analysis and real-time RT-PCR showed a significant increase of the transcript with an out of frame deletion of the last 22nt of exon 5 (BRCA1-Delta22ntex5) and a decrease of the full-length transcript (BRCA1-ex5FL) in patients carrying the R71G mutation as compared to controls, whereas no significant differences were found for the transcript with in frame skipping of exon 5 (BRCA1-Deltaex5). One haplotype was found to segregate in the two informative Portuguese families and in the Galician family. We demonstrate that disruption of alternative transcript ratios is the mechanism causing hereditary breast/ovarian cancer associated with the BRCA1 R71G mutation. Furthermore, our findings indicate a common ancestry of the Portuguese and Galician families sharing this mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19123044     DOI: 10.1007/s10689-008-9229-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  15 in total

1.  Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.

Authors:  Kathleen Claes; Jo Vandesompele; Bruce Poppe; Karine Dahan; Ilse Coene; Anne De Paepe; Ludwine Messiaen
Journal:  Oncogene       Date:  2002-06-13       Impact factor: 9.867

2.  RNA-based analysis of BRCA1 and BRCA2 gene alterations.

Authors:  Fabrizia Bonatti; Chiara Pepe; Mariella Tancredi; Grazia Lombardi; Paolo Aretini; Elisa Sensi; Elisabetta Falaschi; Giovanna Cipollini; Generoso Bevilacqua; Maria Adelaide Caligo
Journal:  Cancer Genet Cytogenet       Date:  2006-10-15

3.  Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

Authors:  Georgia Chenevix-Trench; Sue Healey; Sunil Lakhani; Paul Waring; Margaret Cummings; Ross Brinkworth; Amie M Deffenbaugh; Lynn Anne Burbidge; Dmitry Pruss; Thad Judkins; Tom Scholl; Anna Bekessy; Anna Marsh; Paul Lovelock; Ming Wong; Andrea Tesoriero; Helene Renard; Melissa Southey; John L Hopper; Koulis Yannoukakos; Melissa Brown; Douglas Easton; Sean V Tavtigian; David Goldgar; Amanda B Spurdle
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

Review 4.  Real-time PCR quantification of precursor and mature microRNA.

Authors:  Thomas D Schmittgen; Eun Joo Lee; Jinmai Jiang; Anasuya Sarkar; Liuqing Yang; Terry S Elton; Caifu Chen
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

5.  Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.

Authors:  D A Favy; S Lafarge; P Rio; C Vissac; Y J Bignon; D Bernard-Gallon
Journal:  Biochem Biophys Res Commun       Date:  2000-07-21       Impact factor: 3.575

6.  Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families.

Authors:  A A Tesoriero; E M Wong; M A Jenkins; J L Hopper; M A Brown; G Chenevix-Trench; A B Spurdle; M C Southey
Journal:  Hum Mutat       Date:  2005-11       Impact factor: 4.878

Review 7.  The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications.

Authors:  Emiliano Honrado; Javier Benítez; José Palacios
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

8.  Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis.

Authors:  O Lungu; T C Wright; S Silverstein
Journal:  Mol Cell Probes       Date:  1992-04       Impact factor: 2.365

9.  Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

Authors:  Tari A King; Weiwei Li; Edi Brogi; Cindy J Yee; Mary L Gemignani; Narciso Olvera; Douglas A Levine; Larry Norton; Mark E Robson; Kenneth Offit; Patrick I Borgen; Jeff Boyd
Journal:  Ann Surg Oncol       Date:  2007-06-29       Impact factor: 5.344

10.  The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.

Authors:  Ana Peixoto; Catarina Santos; Patrícia Rocha; Manuela Pinheiro; Sofia Príncipe; Deolinda Pereira; Helena Rodrigues; Fernando Castro; Joaquim Abreu; Leonor Gusmão; António Amorim; Manuel R Teixeira
Journal:  Breast Cancer Res Treat       Date:  2008-03-25       Impact factor: 4.872

View more
  3 in total

Review 1.  Genetic Cancer Risk Assessment for Breast Cancer in Latin America.

Authors:  Yanin Chavarri-Guerra; Kathleen Reilly Blazer; Jeffrey Nelson Weitzel
Journal:  Rev Invest Clin       Date:  2017 Mar-Apr       Impact factor: 1.451

2.  Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.

Authors:  Gabriela Es Felix; Camila Abe-Sandes; Taísa Mb Machado-Lopes; Thaís F Bomfim; Rodrigo Santa Cruz Guindalini; Vanessa Catarine Sar Santos; Lorena Meyer; Polyanna C Oliveira; João Cláudio Neiva; Roberto Meyer; Maura Romeo; Maria Betânia Toralles; Ivana Nascimento; Kiyoko Abe-Sandes
Journal:  Hum Genome Var       Date:  2014-10-16

3.  A Multi-Center Study of BRCA1 and BRCA2 Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population.

Authors:  Oliver Millan Catalan; Alma D Campos-Parra; Rafael Vázquez-Romo; David Cantú de León; Nadia Jacobo-Herrera; Fermín Morales-González; César López-Camarillo; Mauricio Rodríguez-Dorantes; Eduardo López-Urrutia; Carlos Pérez-Plasencia
Journal:  Cancers (Basel)       Date:  2019-08-26       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.